ストックスクリーナーアプリを入手
9.62
8.56%
-0.90
プレマーケット:
9.62
Nextcure Inc (NXTC) 最新ニュース
NextCure (NASDAQ: NXTC) plans 2026 meeting, auditor, pay and equity plan votes - Stock Titan
NextCure to present SIM0505 cancer drug data at ASCO meeting - Investing.com
NextCure to present SIM0505 cancer drug data at ASCO meeting By Investing.com - Investing.com Canada
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 - The Manila Times
NextCure and Simcere Announce Presentation of Phase 1 Data for SIM0505 at ASCO 2026 - Quiver Quantitative
NextCure Inc stock (US65343E1082): Is its immunotherapy pipeline strong enough to unlock biotech ups - AD HOC NEWS
Ladenburg Thalmann Upgrades NextCure (NXTC) - MSN
NXTC Forecast, Price Target & Analyst Ratings | NEXTCURE INC (NASDAQ:NXTC) - ChartMill
Resistance Check: Will Argan Inc benefit from rate cutsPortfolio Update Report & Risk Managed Trade Strategies - baoquankhu1.vn
GUOCHUN INTERNATIONAL INC. Reports No Revenue and Material Weaknesses in Q3 2025 10-Q/A Filing - Minichart
Published on: 2026-04-09 04:19:51 - baoquankhu1.vn
Surprises Report: Is NextCure Inc stock good for income investorsNew Guidance & Safe Entry Trade Signal Reports - baoquankhu1.vn
FDA Gives Fast Track Status to SIM0505 in Platinum-Resistant Ovarian Cancer - CancerNetwork
Activity Recap: Is NextCure Inc a defensive stock2026 News Drivers & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Is NextCure (NXTC) Stock heavily shorted | Price at $12.10, Up 8.67%Vega Volatility - Cổng thông tin điện tử Tỉnh Sơn La
Value Recap: How is NextCure Inc managing supply chain issues2026 Geopolitical Influence & Verified Short-Term Plans - baoquankhu1.vn
NextCure Gets FDA Fast Track for SIM0505 in Ovarian Cancer - National Today
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer - Bitget
FDA fast-tracks NextCure ovarian cancer drug ahead of ASCO data - Stock Titan
Resistance Check: Is NextCure Inc exposed to currency risksMarket Performance Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Trend Report: Will Investcorp Credit Management BDC Inc Preferred Security outperform tech stocksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
NXTC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Sacral Fracture Risk After Short-Course RT for Rectal Cancer - Medscape
NXTC Stock Analysis: NextCure Inc. Biotech Gains 1.80 Percent to 10.72 Support Level - Xã Thanh Hà
Buyout Rumor: Will American Tower Corporation stock go up in YEAR2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn
NXTC Should I Buy - Intellectia AI
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026 - The Manila Times
Phase 1 cancer drug abstract lands ASCO 2026 slot in Chicago - Stock Titan
Price Action: Is Oriental Culture Holding LTD stock a top performer YTD2026 Selloffs & Daily Entry Point Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
BLRX PE Ratio & Valuation, Is BLRX Overvalued - Intellectia AI
Bond Watch: Is NextCure Inc stock showing strong momentumQuarterly Portfolio Summary & Verified Entry Point Signals - baoquankhu1.vn
NextCure, Inc.Common Stock (NQ: NXTC - FinancialContent
Retail Trends: Why is GGNPRB stock going downLong Setup & Smart Investment Allocation Insights - baoquankhu1.vn
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NIVFPrice, Charts & Blockchain Insights - Intellectia AI
ITVI Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
MMMM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Buy Signal: Is NextCure Inc a defensive stockQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Action: Is CF Bankshares Incs growth already priced in2026 Chart Watch & Proven Capital Preservation Methods - baoquankhu1.vn
Published on: 2026-03-22 18:56:49 - baoquankhu1.vn
BOLD Technical Analysis & Price Forecast - Intellectia AI
LOW Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HTH Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
BKT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BSX Technical Analysis & Price Forecast - Intellectia AI
CULP Should I Buy - Intellectia AI
Travel Stocks: Is NextCure Inc stock good for income investorsTrade Risk Assessment & AI Forecast Swing Trade Picks - baoquankhu1.vn
NextCure Inc Stock (ISIN: US65343E1082) Faces Analyst Downgrade Amid Biotech Sector Headwinds - AD HOC NEWS
NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment - MSN
NextCure Provides Business Update and Reports Full Year 2025 Financial Results - The Manila Times
NextCure Inc reports results for the quarter ended September 30Earnings Summary - TradingView
NextCure 10-K: $0 Revenue, $(19.65) EPS reported - TradingView
NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NXTC SEC FilingsNextcure 10-K, 10-Q, 8-K Forms - Stock Titan
1.61%
3.22%
大文字化:
|
ボリューム (24 時間):